Literature DB >> 22222197

Left atrial enlargement is associated with a rapid decline in residual renal function in ESRD patients on peritoneal dialysis.

Seung Jun Kim1, Hyung Jung Oh, Dong Eun Yoo, Dong Ho Shin, Mi Jung Lee, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Kyu Hun Choi, Shin-Wook Kang.   

Abstract

BACKGROUND: Left atrial (LA) volume index (LAVI) has been considered a stable indicator of diastolic dysfunction and an independent predictor of mortality in patients with end-stage renal disease. To date, however, little is known about the relationship between LA enlargement and the changes in residual renal function (RRF).
METHODS: This study was undertaken to investigate the association between LA enlargement and the decline in RRF in 121 incident peritoneal dialysis patients. Within 2 months after the initiation of peritoneal dialysis, LA enlargement was determined by echocardiography and RRF by 24-hour urine collection. Subsequently, RRF was measured every 6 months.
RESULTS: The rates of decline in RRF were significantly greater in patients with LA enlargement (LAVI > 32 mL/m(2)) compared with those without LA enlargement (-0.17 ± 0.18 vs -0.07 ± 0.16 mL/min/month/1.73 m(2), P = .002). In a linear mixed model, there was a significant difference in the rates of RRF decline over time between patients with and without LA enlargement (P < .001). Pearson's correlation analysis revealed that there were significant inverse correlations between the rates of the decline in RRF and LAVI (r = -0.22, P = .018). In multiple linear regression analysis adjusted for other risk factors, LAVI was found to be an independent determinant of the rates of decline in RRF (β = -0.026, P = .018).
CONCLUSIONS: This study shows that a higher LAVI is independently associated with a more rapid decline in RRF in patients with end-stage renal disease on peritoneal dialysis.
Copyright © 2012 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22222197     DOI: 10.1016/j.echo.2011.12.005

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  Left atrial volume index is a predictor of silent myocardial ischemia in high-risk patients with end-stage renal disease.

Authors:  Myung Jin Choi; Jwa-Kyung Kim; Sung Gyun Kim; Joung Woo Yoon; Ja Ryong Koo; Hyung Jik Kim; Young Rim Song
Journal:  Int J Cardiovasc Imaging       Date:  2013-05-09       Impact factor: 2.357

2.  Comparison of the impact of "fast decline" in residual renal function and "initial anuria" on long-term outcomes in CAPD patients.

Authors:  Yi-Hua Lu; Jyh-Chang Hwang; Ming-Yan Jiang; Charn-Ting Wang
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

Review 3.  Controversies in timing of dialysis initiation and the role of race and demographics.

Authors:  Elani Streja; Susanne B Nicholas; Keith C Norris
Journal:  Semin Dial       Date:  2013-09-19       Impact factor: 3.455

4.  Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients.

Authors:  Hyang Mo Koo; Fa Mee Doh; Chan Ho Kim; Mi Jung Lee; Eun Jin Kim; Jae Hyun Han; Ji Suk Han; Dong-Ryeol Ryu; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Shin-Wook Kang
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

5.  Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic function.

Authors:  Jae Hyun Han; Ji Suk Han; Eun Jin Kim; Fa Mee Doh; Hyang Mo Koo; Chan Ho Kim; Mi Jung Lee; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Dong-Ryeol Ryu; Tae-Hyun Yoo; Shin-Wook Kang
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

6.  Associations between echocardiographic findings and prospective changes in residual renal function in patients new to peritoneal dialysis.

Authors:  Sara Mahdavi; Kibar Yared; George Wu; Billy Omar; Dinesh Savundra; Gordon Nagai; Edgar Hockmann; Anton Svendrovski; Antonio Bellasi; Paul Tam; Tabo Sikaneta
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.